Showing results (111-120 of 259) with videos related to
Sort By:
Pageof 26
Brain Research|January 30, 2002
New dopamine D2 receptor polymorphisms in rats and association with apomorphine-induced stereotypiesSabine Germeyer, Andrea Birke, Ulrich Schmitt, et al.Neuroscience Letters|September 25, 2002
Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetineChristian Plewnia, Julia Hoppe, Christoph Hiemke, et al.Journal of Clinical Pharmacology|September 17, 2013
Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactionsMaximilian Gahr, Roland W Freudenmann, Bernhard J Connemann, et al.European Journal of Clinical Pharmacology|January 8, 2013
Pregabalin abuse and dependence in Germany: results from a database queryMaximilian Gahr, Roland W Freudenmann, Christoph Hiemke, et al.The Journal of Clinical Psychiatry|March 29, 2006
St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infantsClaudia M Klier, Brigitte Schmid-Siegel, Miriam R Schäfer, et al.International Journal of Molecular Sciences|August 7, 2021
Loss of mGluR5 in D1 Receptor-Expressing Neurons Improves Stress CopingLuca Zangrandi, Claudia Schmuckermair, Hussein Ghareh, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 7, 2021
Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patientsDomenico De Donatis, Stefano Porcelli, Gerald Zernig, et al.Psychopharmacology|August 24, 2014
Distribution pattern of mirtazapine and normirtazapine in blood and CSFMichael Paulzen, Gerhard Gründer, Simone C Tauber, et al.Psychopharmacology|September 17, 2009
Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over studyBarbara Drueke, Julia Baetz, Maren Boecker, et al.Therapeutic Drug Monitoring|February 20, 2024
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug ReactionsMaxim Kuzin, Ekkehard Haen, Nazar Kuzo, et al.Pageof 26